publication date: May. 27, 2016

Survey: 28 Percent of Doctors

See Clinical Trials as Last Resort



Only 40 percent of Americans have a positive overall impression of clinical trials, according to a national survey conducted for Memorial Sloan Kettering Cancer Center.

The survey, which polled over 2,100 people including nearly 600 physicians, found that 28 percent of doctors considered clinical trials as treatments of last resort.

One-third, or 32 percent, of doctors polled said they discuss the topic with their patients at the beginning of treatment—however, 56 percent said they consider clinical trials late in treatment.

The main concerns cited by patients included worries over side effects, uncertainty about insurance and costs, concerns about receiving a placebo or skepticism of unproven treatments, and feeling like “guinea pigs.” Only 35 percent indicated that they were likely to enroll in a clinical trial. These concerns were also echoed by physicians.

“When it comes to advancing cancer care, clinical research is the rocket fuel for better treatments, more accurate diagnoses, and, ultimately, cures,” said José Baselga, physician-in-chief and chief medical officer at MSK, which is currently involved in over 900 cancer clinical trials. “If this trend of low enrollment continues, we will face a crisis in cancer research and discovery. Further education is the key to participation and progress.”

According to MSK, other studies have shown that only 4 percent of cancer patients enroll in clinical trials nationally each year.

“While concerns … Continue reading 42-21 Survey: 28 Percent of Doctors See Clinical Trials as Last Resort

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.